ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar RazorSphinx (< 20) Submitted: 4/28/2011 7:34:29 AM : Outperform Start Price: $20.56 VPHM Score: +0.32

Magic Formula

Report this Post Reply

Featured Broker Partners


Advertisement